Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHL2401170	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(2.4)	New Drug Application	2024-11-05		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHB2400082	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(2.4)	Supplementary Application	2024-04-09		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHB2400070	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(1)	Supplementary Application	2024-03-21		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHB2300246	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(2.4)	Supplementary Application	2023-12-07		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHS2300057	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(2.4)	New Drug Application	2023-06-21		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHL2300432	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(2.4)	New Drug Application	2023-04-25		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHB2300047	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(2.4)	Supplementary Application	2023-03-02		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHL2200838	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(2.4)	New Drug Application	2022-10-28		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CYHB2201181	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(1)	Supplementary Application	2022-07-15		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHB2200070	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(2.4)	Supplementary Application	2022-05-10		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHB2200027	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(2.4)	Supplementary Application	2022-03-03		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CYHB2200307	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(2.4)	Supplementary Application	2022-02-11		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CYHB2200296	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(1)	Supplementary Application	2022-02-10		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHS2200007	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(2.4)	New Drug Application	2022-01-28		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CYHS2200112	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(3)	Generic Drug	2022-01-18		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHB2101135	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(原1.1)	Supplementary Application	2021-10-28		BeiGene (Beijing) Co Ltd			view
CXHL2101615	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(2.4)	New Drug Application	2021-10-27		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHB2101013	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(2.4)	Supplementary Application	2021-04-23		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHB2101014	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(2.4)	Supplementary Application	2021-04-23		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHB2100057	泽布替尼胶囊	zanubrutinib	Capsule	Chemical Drugs(原1.1)	Supplementary Application	2021-04-10	百济神州（北京）生物科技有限公司	BeiGene (Beijing) Co Ltd	In Review	2022-01-27	view